Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liaoning Huaren Pharmaceutical Co., Ltd. is a prominent subsidiary of the publicly traded Huaren Pharmaceutical Co., Ltd. (SZSE: 300110), specializing in the production of large-volume parenterals (LVP) and specialized medical solutions. Based in Shenyang, China, the company is a major provider of non-PVC soft bag infusions, with a core focus on the nephrology market through its peritoneal dialysis fluids. Its product portfolio also includes a wide range of therapeutic infusions, such as anti-infectives, nutrient solutions, and electrolyte balancers. The company operates high-capacity GMP-certified manufacturing facilities designed to meet clinical demands for safe and efficient drug delivery systems. Liaoning Huaren plays a strategic role in the parent group's dominance in the domestic Chinese infusion and renal care sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liaoning Huaren Pharmaceutical.